Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Dec 28;34(6):588–596. doi: 10.1200/JCO.2015.64.0987

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 by American Society of Clinical Oncology

PMC Copyright notice

Fig A1. — A 46-year-old patient with multiple endocrine neoplasia type 1 and known pancreatic and duodenal lesions who had lymph nodes not previously known that were detected by using ⁶⁸Ga-DOTATATE positron emission tomography (PET)/computed tomography (CT) imaging. (A) ¹¹¹In-Pentetreotide scan (planar) shows a unique unclear prerenal uptake. (B, top) Axial CT, (middle) ¹¹¹In-pentetreotide axial slice, and (bottom) fused single-photo emission CT/CT showing unclear pathologic uptake (red arrow). (C) ⁶⁸Ga-DOTATATE PET maximum-intensity projection image shows retropancreatic lymph node (red arrow) and duodenal and pancreatic lesions. (D) ⁶⁸Ga-DOTATATE Q:17 PET/CT image shows the retropancreatic and periduodenal lymph node (maximum standardized uptake value, 96; red arrow). (E) Arterial phase CT shows corresponding lymph node (red arrow) that was read as a subcentimeter indeterminate lymph node.